jamesbondpinball| Aojing Medical: Acquires 100% equity interest in HumanTech Dental GmbH in Germany

Newsletter summary

Aojing Medical: acquisition of shares in HumanTechDentalGmbH100% of GermanyJamesbondpinballAojing Medical (688613) issued an announcement on the evening of April 25th.JamesbondpinballWith its own funds 324Jamesbondpinball.60 thousand euros (about 0 yuan)Jamesbondpinball2.5 billion yuan) acquisition of HutzelDrehTechGmbH (referred to as "Hutzel Group").

Text of news flash

Aojing Medical: acquisition of shares in German HumanTechDentalGmbH100% Securities Times News, Aojing Medical (688613) issued an announcement on the evening of April 25th, with its own funds of 3.246 million euros (about 25 million yuan) to acquire the 100% equity of HumanTechDentalGmbH100 held by HutzelDrehTechGmbH (referred to as "Hutzel Group"). After the completion of this acquisition, HumanTechDentalGmbH becomes a wholly owned subsidiary of Aojing Medical, which is included in the scope of the company's consolidated statements. The announcement said that the acquisition of 100% equity interest in HumanTechDentalGmbH of Germany does not constitute a related party transaction, nor does it constitute a major asset restructuring stipulated in the "measures for the Management of Major Asset restructuring of listed companies". This transaction does not need to be considered by the board of directors and does not need to be submitted to the general meeting of shareholders of the company for consideration. According to reports, Hutzel Group is a medium-sized family business in Germany, with subsidiaries in Germany, the Czech Republic and Mexico. Self-branded spinal implants and oral implants are the two main businesses of Hutzel Group in the medical sector. HumanTechDental, a subsidiary of the Hutzel Group with a registered share capital of 30, 000 euros, was established on May 5, 2017, mainly responsible for the development, manufacture and sale of oral implants and related oral medical products. Among them, oral implants are in a leading position in product safety and reliability in the research and development and application of similar products. The company has a strong R & D strength, with a number of trademarks, patents and a number of proprietary technologies developed by ourselves. HumanTechDental's oral implants and accessories, supporting tools and other products obtained EU CE certification in 2014, Chinese CFDA (now NMPA) registration certificate in 2016, Mexico registration certificate in 2019, Egypt registration certificate in 2021 and Malaysia registration certificate in 2022. Aojing Medical said that after investing in HumanTechDental and holding 100% of its shares, it can enrich the company's oral business line products, form a reasonable product line gradient and business synergy with existing oral biomaterials products, and greatly promote the development of the company in the field of oral medicine. In the field of stomatology in China, the dental implants and Ortho-essence artificial bone repair products of HumanTechDental Company (20193171523) are used in oral implant surgery, which can be used together with each other, and the product has a high synergistic effect. Dental implants and artificial bone repair materials are high-value dental consumables. At present, the main sales channels of HumanTechDental and Aojing Medical in China are agent distribution mode, and the end customers are public hospitals stomatology department, public dental hospitals, private oral chain institutions, private oral clinics, sales channels and high degree of customer cooperation. Aojing Medical also said that this acquisition will help to further consolidate the company's leading position in the oral field, improve the company's product innovation and R & D strength, and further enrich the company's product line layout. promote the effective implementation of the company's long-term, sustained, stable development and international strategy, and further improve the company's core competitiveness and sustainable development ability. Proofread: Liu Rongzhi